Ask a Question
  • Women's Health
  • Oncology
  • Cardio Renal
  • Ophthalmology
The Combination of Enzalutamide and Radium-223 in mCRPC
PPTX / 4061KB
PreviewvisibilityDownloaddownload
Oncology

The Combination of Enzalutamide and Radium-223 in mCRPC

This slide deck provides an overview of the EORTC-1333/PEACE-3 study, investigating enzalutamide and Ra223 compared to enzalutamide single agent in patients with mCRPC. 

 

MA-PFM-ONC-CA-0066-1

Related Content

Bayer Oncology Pipeline Deck 2025
This slide deck provides an overview of Bayer's oncology R&D strategy and pipeline for ongoing phase 1-3 trials.
ASCO 2025 Bayer-Sponsored Prostate Cancer Highlights
This slide deck provides an overview of the Bayer-sponsored prostate cancer abstracts presented at ASCO 2025 in Chica...
ASCO GU 2025 Bayer-Sponsored Prostate Cancer Highlights
This slide deck provides an overview of the Bayer-sponsored prostate cancer abstracts presented at ASCO GU 2025 in Sa...